Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer
Page (1) of 1 - 01/12/18||
This article is no longer available,but here are some related topics.
All Rights Reserved